- Home
- JFU vs PMVP Comparison
JFU vs PMVP Comparison
Compare JFU & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFU | PMVP |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.2M | 68.9M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JFU | PMVP |
|---|---|---|
| Price | $7.37 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 11.7K | ★ 262.9K |
| Earning Date | 12-09-2022 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3110.57 | N/A |
| EPS | ★ 3.04 | N/A |
| Revenue | ★ $44,573,690.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.78 | ★ N/A |
| Revenue Growth | ★ 8.19 | N/A |
| 52 Week Low | $1.01 | $0.81 |
| 52 Week High | $9.48 | $1.84 |
Technical Indicators
Market Signals| Indicator | JFU | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 70.30 | 41.76 |
| Support Level | $4.57 | $1.14 |
| Resistance Level | $4.94 | $1.30 |
| Average True Range (ATR) | 0.70 | 0.06 |
| MACD | 0.34 | -0.00 |
| Stochastic Oscillator | 60.04 | 39.13 |
Price Performance
Historical ComparisonAbout JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.